D-Ribose Applications Research
Researchers began to study ribose in the 1930s but did not begin to understand its importance until the 1950s when research techniques became sophisticated enough to investigate the intricate metabolic role of ribose in various body tissues. In the mid-1980s, John Foker, M.D., Ph.D., a University of Minnesota cardiovascular surgeon and biochemist, began pioneering research proving the rate limiting impact of ribose availability on recovery from cardiac ischemia. This research triggered a cascade of scientific investigation that has expanded to many tissues and physiological processes. This research continues today. Recent studies have proven that D-Ribose relieves fatigue and pain. One study in particular, performed by Jacob Teitelbaum, MD, and Valen Labs, showed that 69 percent of 39 patients who completed a course of treatment with D-Ribose had a significant improvement in their symptoms. These symptoms included those of fibromyalgia and chronic fatigue syndrome. Although the causes of these conditions are still unknown, D-Ribose seems to ease symptoms by fueling the body’s ATP production.
Physicians have also been performing ongoing research to show the link between D-Ribose and cardiovascular health. Recently the University of Utah assessed the effects of D-Ribose on Congestive Heart Failure patients. This double-blind, placebo-controlled study showed significant improvement of oxygen use and ventilatory efficiency in those patients who were on D-Ribose supplementation.
Many of the benefits associated with D-Ribose still remain unproven by formal medical studies, but physicians continue to work at unraveling its mysteries. Research is ongoing to help the medical community understand the process by which D-Ribose enhances ATP production, and these discoveries will undoubtedly reveal exciting new uses for D-Ribose in the near future.
|